Head to Head Review: Firefly Neuroscience (AIFF) versus Its Peers

Earnings and Valuation

This table compares Firefly Neuroscience and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Firefly Neuroscience	$479,000.00	-$2.03 million	-1.22
Firefly Neuroscience Competitors	$2.51 billion	$326.31 million	-670.55

Firefly Neuroscience’s competitors have higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility & Risk

Firefly Neuroscience has a beta of 3.25, meaning that its stock price is 225% more volatile than the S&P 500. Comparatively, Firefly Neuroscience’s competitors have a beta of 0.45, meaning that their average stock price is 55% less volatile than the S&P 500.

Institutional and Insider Ownership

5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 56.9% of shares of all “Prepackaged software” companies are held by institutional investors. 8.4% of Firefly Neuroscience shares are held by insiders. Comparatively, 18.9% of shares of all “Prepackaged software” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Firefly Neuroscience and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-73.72%	-276.50%	-133.02%
Firefly Neuroscience Competitors	-71.61%	-38.00%	-6.78%

Summary

Firefly Neuroscience competitors beat Firefly Neuroscience on 7 of the 9 factors compared.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.